Global Human Coagulation Factor VIII Supply, Demand and Key Producers, 2026-2032
The global Human Coagulation Factor VIII market size is expected to reach $ 18990 million by 2032, rising at a market growth of 6.2% CAGR during the forecast period (2026-2032).
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
Market Drivers:
The increasing prevalence of hemophilia A is a key driver for the Human Coagulation Factor VIII market. As awareness and diagnosis rates improve, more patients are receiving proper treatment, driving demand for Factor VIII therapies. Additionally, advancements in biotechnology, including the development of recombinant and extended half-life Factor VIII products, have significantly improved treatment efficacy and patient convenience. Government initiatives and healthcare programs supporting rare disease treatments, along with expanded access to hemophilia care in developing regions, further boost market growth. The rise of gene therapy research also presents potential future opportunities for transforming the hemophilia treatment landscape.
Market Challenges:
Despite strong market growth, several challenges persist, including the high cost of Factor VIII therapies, which limits affordability and accessibility for many patients, especially in low-income regions. Additionally, plasma-derived Factor VIII products face supply chain constraints due to reliance on blood donations. Another major challenge is the development of inhibitors (antibodies) in some patients, which can render Factor VIII treatment ineffective and necessitate alternative therapies. Regulatory complexities and the need for stringent quality control in manufacturing also pose barriers for new entrants in the market.
This report studies the global Human Coagulation Factor VIII production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Human Coagulation Factor VIII and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Coagulation Factor VIII that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Human Coagulation Factor VIII total production and demand, 2021-2032, (K Bottles)
Global Human Coagulation Factor VIII total production value, 2021-2032, (USD Million)
Global Human Coagulation Factor VIII production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Bottles), (based on production site)
Global Human Coagulation Factor VIII consumption by region & country, CAGR, 2021-2032 & (K Bottles)
U.S. VS China: Human Coagulation Factor VIII domestic production, consumption, key domestic manufacturers and share
Global Human Coagulation Factor VIII production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Bottles)
Global Human Coagulation Factor VIII production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Bottles)
Global Human Coagulation Factor VIII production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Bottles)
This report profiles key players in the global Human Coagulation Factor VIII market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk, Greencross, Kedrion, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Coagulation Factor VIII market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Bottles) and average price (USD/Bottle) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Human Coagulation Factor VIII Market, By Region:
1. How big is the global Human Coagulation Factor VIII market?
2. What is the demand of the global Human Coagulation Factor VIII market?
3. What is the year over year growth of the global Human Coagulation Factor VIII market?
4. What is the production and production value of the global Human Coagulation Factor VIII market?
5. Who are the key producers in the global Human Coagulation Factor VIII market?
6. What are the growth factors driving the market demand?
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
Market Drivers:
The increasing prevalence of hemophilia A is a key driver for the Human Coagulation Factor VIII market. As awareness and diagnosis rates improve, more patients are receiving proper treatment, driving demand for Factor VIII therapies. Additionally, advancements in biotechnology, including the development of recombinant and extended half-life Factor VIII products, have significantly improved treatment efficacy and patient convenience. Government initiatives and healthcare programs supporting rare disease treatments, along with expanded access to hemophilia care in developing regions, further boost market growth. The rise of gene therapy research also presents potential future opportunities for transforming the hemophilia treatment landscape.
Market Challenges:
Despite strong market growth, several challenges persist, including the high cost of Factor VIII therapies, which limits affordability and accessibility for many patients, especially in low-income regions. Additionally, plasma-derived Factor VIII products face supply chain constraints due to reliance on blood donations. Another major challenge is the development of inhibitors (antibodies) in some patients, which can render Factor VIII treatment ineffective and necessitate alternative therapies. Regulatory complexities and the need for stringent quality control in manufacturing also pose barriers for new entrants in the market.
This report studies the global Human Coagulation Factor VIII production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Human Coagulation Factor VIII and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Coagulation Factor VIII that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Human Coagulation Factor VIII total production and demand, 2021-2032, (K Bottles)
Global Human Coagulation Factor VIII total production value, 2021-2032, (USD Million)
Global Human Coagulation Factor VIII production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Bottles), (based on production site)
Global Human Coagulation Factor VIII consumption by region & country, CAGR, 2021-2032 & (K Bottles)
U.S. VS China: Human Coagulation Factor VIII domestic production, consumption, key domestic manufacturers and share
Global Human Coagulation Factor VIII production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Bottles)
Global Human Coagulation Factor VIII production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Bottles)
Global Human Coagulation Factor VIII production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Bottles)
This report profiles key players in the global Human Coagulation Factor VIII market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk, Greencross, Kedrion, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Coagulation Factor VIII market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Bottles) and average price (USD/Bottle) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Human Coagulation Factor VIII Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Recombinant Factor VIII
- Plasma-derived Factor VIII
- Hemophilia A
- Spontanous / Trauma
- Surgical
- Other
- Takeda
- Bayer
- CSL
- Pfizer
- Grifols
- Biogen
- Octapharma
- NovoNordisk
- Greencross
- Kedrion
- BPL
- Hualan Bio
- RAAS
- SinoCellTech
- Taibang Bio
- Huarun Boya
- Shuanglin Bio
- Yuandashuyang
- Weiguang Bio
1. How big is the global Human Coagulation Factor VIII market?
2. What is the demand of the global Human Coagulation Factor VIII market?
3. What is the year over year growth of the global Human Coagulation Factor VIII market?
4. What is the production and production value of the global Human Coagulation Factor VIII market?
5. Who are the key producers in the global Human Coagulation Factor VIII market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Human Coagulation Factor VIII Introduction
1.2 World Human Coagulation Factor VIII Supply & Forecast
1.2.1 World Human Coagulation Factor VIII Production Value (2021 & 2025 & 2032)
1.2.2 World Human Coagulation Factor VIII Production (2021-2032)
1.2.3 World Human Coagulation Factor VIII Pricing Trends (2021-2032)
1.3 World Human Coagulation Factor VIII Production by Region (Based on Production Site)
1.3.1 World Human Coagulation Factor VIII Production Value by Region (2021-2032)
1.3.2 World Human Coagulation Factor VIII Production by Region (2021-2032)
1.3.3 World Human Coagulation Factor VIII Average Price by Region (2021-2032)
1.3.4 North America Human Coagulation Factor VIII Production (2021-2032)
1.3.5 Europe Human Coagulation Factor VIII Production (2021-2032)
1.3.6 China Human Coagulation Factor VIII Production (2021-2032)
1.3.7 Korea Human Coagulation Factor VIII Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Human Coagulation Factor VIII Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Human Coagulation Factor VIII Major Market Trends
2 DEMAND SUMMARY
2.1 World Human Coagulation Factor VIII Demand (2021-2032)
2.2 World Human Coagulation Factor VIII Consumption by Region
2.2.1 World Human Coagulation Factor VIII Consumption by Region (2021-2026)
2.2.2 World Human Coagulation Factor VIII Consumption Forecast by Region (2027-2032)
2.3 United States Human Coagulation Factor VIII Consumption (2021-2032)
2.4 China Human Coagulation Factor VIII Consumption (2021-2032)
2.5 Europe Human Coagulation Factor VIII Consumption (2021-2032)
2.6 Japan Human Coagulation Factor VIII Consumption (2021-2032)
2.7 South Korea Human Coagulation Factor VIII Consumption (2021-2032)
2.8 ASEAN Human Coagulation Factor VIII Consumption (2021-2032)
2.9 India Human Coagulation Factor VIII Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Human Coagulation Factor VIII Production Value by Manufacturer (2021-2026)
3.2 World Human Coagulation Factor VIII Production by Manufacturer (2021-2026)
3.3 World Human Coagulation Factor VIII Average Price by Manufacturer (2021-2026)
3.4 Human Coagulation Factor VIII Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Human Coagulation Factor VIII Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Human Coagulation Factor VIII in 2025
3.5.3 Global Concentration Ratios (CR8) for Human Coagulation Factor VIII in 2025
3.6 Human Coagulation Factor VIII Market: Overall Company Footprint Analysis
3.6.1 Human Coagulation Factor VIII Market: Region Footprint
3.6.2 Human Coagulation Factor VIII Market: Company Product Type Footprint
3.6.3 Human Coagulation Factor VIII Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Human Coagulation Factor VIII Production Value Comparison
4.1.1 United States VS China: Human Coagulation Factor VIII Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Human Coagulation Factor VIII Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Human Coagulation Factor VIII Production Comparison
4.2.1 United States VS China: Human Coagulation Factor VIII Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Human Coagulation Factor VIII Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Human Coagulation Factor VIII Consumption Comparison
4.3.1 United States VS China: Human Coagulation Factor VIII Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Human Coagulation Factor VIII Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Human Coagulation Factor VIII Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Human Coagulation Factor VIII Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Human Coagulation Factor VIII Production Value (2021-2026)
4.4.3 United States Based Manufacturers Human Coagulation Factor VIII Production (2021-2026)
4.5 China Based Human Coagulation Factor VIII Manufacturers and Market Share
4.5.1 China Based Human Coagulation Factor VIII Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Human Coagulation Factor VIII Production Value (2021-2026)
4.5.3 China Based Manufacturers Human Coagulation Factor VIII Production (2021-2026)
4.6 Rest of World Based Human Coagulation Factor VIII Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Human Coagulation Factor VIII Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Human Coagulation Factor VIII Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Human Coagulation Factor VIII Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Human Coagulation Factor VIII Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Recombinant Factor VIII
5.2.2 Plasma-derived Factor VIII
5.3 Market Segment by Type
5.3.1 World Human Coagulation Factor VIII Production by Type (2021-2032)
5.3.2 World Human Coagulation Factor VIII Production Value by Type (2021-2032)
5.3.3 World Human Coagulation Factor VIII Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Human Coagulation Factor VIII Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Hemophilia A
6.2.2 Spontanous / Trauma
6.2.3 Surgical
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Human Coagulation Factor VIII Production by Application (2021-2032)
6.3.2 World Human Coagulation Factor VIII Production Value by Application (2021-2032)
6.3.3 World Human Coagulation Factor VIII Average Price by Application (2021-2032)
7 COMPANY PROFILES
7.1 Takeda
7.1.1 Takeda Details
7.1.2 Takeda Major Business
7.1.3 Takeda Human Coagulation Factor VIII Product and Services
7.1.4 Takeda Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.1.5 Takeda Recent Developments/Updates
7.1.6 Takeda Competitive Strengths & Weaknesses
7.2 Bayer
7.2.1 Bayer Details
7.2.2 Bayer Major Business
7.2.3 Bayer Human Coagulation Factor VIII Product and Services
7.2.4 Bayer Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.2.5 Bayer Recent Developments/Updates
7.2.6 Bayer Competitive Strengths & Weaknesses
7.3 CSL
7.3.1 CSL Details
7.3.2 CSL Major Business
7.3.3 CSL Human Coagulation Factor VIII Product and Services
7.3.4 CSL Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.3.5 CSL Recent Developments/Updates
7.3.6 CSL Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer Human Coagulation Factor VIII Product and Services
7.4.4 Pfizer Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 Grifols
7.5.1 Grifols Details
7.5.2 Grifols Major Business
7.5.3 Grifols Human Coagulation Factor VIII Product and Services
7.5.4 Grifols Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.5.5 Grifols Recent Developments/Updates
7.5.6 Grifols Competitive Strengths & Weaknesses
7.6 Biogen
7.6.1 Biogen Details
7.6.2 Biogen Major Business
7.6.3 Biogen Human Coagulation Factor VIII Product and Services
7.6.4 Biogen Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.6.5 Biogen Recent Developments/Updates
7.6.6 Biogen Competitive Strengths & Weaknesses
7.7 Octapharma
7.7.1 Octapharma Details
7.7.2 Octapharma Major Business
7.7.3 Octapharma Human Coagulation Factor VIII Product and Services
7.7.4 Octapharma Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.7.5 Octapharma Recent Developments/Updates
7.7.6 Octapharma Competitive Strengths & Weaknesses
7.8 NovoNordisk
7.8.1 NovoNordisk Details
7.8.2 NovoNordisk Major Business
7.8.3 NovoNordisk Human Coagulation Factor VIII Product and Services
7.8.4 NovoNordisk Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.8.5 NovoNordisk Recent Developments/Updates
7.8.6 NovoNordisk Competitive Strengths & Weaknesses
7.9 Greencross
7.9.1 Greencross Details
7.9.2 Greencross Major Business
7.9.3 Greencross Human Coagulation Factor VIII Product and Services
7.9.4 Greencross Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.9.5 Greencross Recent Developments/Updates
7.9.6 Greencross Competitive Strengths & Weaknesses
7.10 Kedrion
7.10.1 Kedrion Details
7.10.2 Kedrion Major Business
7.10.3 Kedrion Human Coagulation Factor VIII Product and Services
7.10.4 Kedrion Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.10.5 Kedrion Recent Developments/Updates
7.10.6 Kedrion Competitive Strengths & Weaknesses
7.11 BPL
7.11.1 BPL Details
7.11.2 BPL Major Business
7.11.3 BPL Human Coagulation Factor VIII Product and Services
7.11.4 BPL Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.11.5 BPL Recent Developments/Updates
7.11.6 BPL Competitive Strengths & Weaknesses
7.12 Hualan Bio
7.12.1 Hualan Bio Details
7.12.2 Hualan Bio Major Business
7.12.3 Hualan Bio Human Coagulation Factor VIII Product and Services
7.12.4 Hualan Bio Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.12.5 Hualan Bio Recent Developments/Updates
7.12.6 Hualan Bio Competitive Strengths & Weaknesses
7.13 RAAS
7.13.1 RAAS Details
7.13.2 RAAS Major Business
7.13.3 RAAS Human Coagulation Factor VIII Product and Services
7.13.4 RAAS Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.13.5 RAAS Recent Developments/Updates
7.13.6 RAAS Competitive Strengths & Weaknesses
7.14 SinoCellTech
7.14.1 SinoCellTech Details
7.14.2 SinoCellTech Major Business
7.14.3 SinoCellTech Human Coagulation Factor VIII Product and Services
7.14.4 SinoCellTech Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.14.5 SinoCellTech Recent Developments/Updates
7.14.6 SinoCellTech Competitive Strengths & Weaknesses
7.15 Taibang Bio
7.15.1 Taibang Bio Details
7.15.2 Taibang Bio Major Business
7.15.3 Taibang Bio Human Coagulation Factor VIII Product and Services
7.15.4 Taibang Bio Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.15.5 Taibang Bio Recent Developments/Updates
7.15.6 Taibang Bio Competitive Strengths & Weaknesses
7.16 Huarun Boya
7.16.1 Huarun Boya Details
7.16.2 Huarun Boya Major Business
7.16.3 Huarun Boya Human Coagulation Factor VIII Product and Services
7.16.4 Huarun Boya Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.16.5 Huarun Boya Recent Developments/Updates
7.16.6 Huarun Boya Competitive Strengths & Weaknesses
7.17 Shuanglin Bio
7.17.1 Shuanglin Bio Details
7.17.2 Shuanglin Bio Major Business
7.17.3 Shuanglin Bio Human Coagulation Factor VIII Product and Services
7.17.4 Shuanglin Bio Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.17.5 Shuanglin Bio Recent Developments/Updates
7.17.6 Shuanglin Bio Competitive Strengths & Weaknesses
7.18 Yuandashuyang
7.18.1 Yuandashuyang Details
7.18.2 Yuandashuyang Major Business
7.18.3 Yuandashuyang Human Coagulation Factor VIII Product and Services
7.18.4 Yuandashuyang Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.18.5 Yuandashuyang Recent Developments/Updates
7.18.6 Yuandashuyang Competitive Strengths & Weaknesses
7.19 Weiguang Bio
7.19.1 Weiguang Bio Details
7.19.2 Weiguang Bio Major Business
7.19.3 Weiguang Bio Human Coagulation Factor VIII Product and Services
7.19.4 Weiguang Bio Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.19.5 Weiguang Bio Recent Developments/Updates
7.19.6 Weiguang Bio Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Human Coagulation Factor VIII Industry Chain
8.2 Human Coagulation Factor VIII Upstream Analysis
8.2.1 Human Coagulation Factor VIII Core Raw Materials
8.2.2 Main Manufacturers of Human Coagulation Factor VIII Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Human Coagulation Factor VIII Production Mode
8.6 Human Coagulation Factor VIII Procurement Model
8.7 Human Coagulation Factor VIII Industry Sales Model and Sales Channels
8.7.1 Human Coagulation Factor VIII Sales Model
8.7.2 Human Coagulation Factor VIII Typical Distributors
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Human Coagulation Factor VIII Introduction
1.2 World Human Coagulation Factor VIII Supply & Forecast
1.2.1 World Human Coagulation Factor VIII Production Value (2021 & 2025 & 2032)
1.2.2 World Human Coagulation Factor VIII Production (2021-2032)
1.2.3 World Human Coagulation Factor VIII Pricing Trends (2021-2032)
1.3 World Human Coagulation Factor VIII Production by Region (Based on Production Site)
1.3.1 World Human Coagulation Factor VIII Production Value by Region (2021-2032)
1.3.2 World Human Coagulation Factor VIII Production by Region (2021-2032)
1.3.3 World Human Coagulation Factor VIII Average Price by Region (2021-2032)
1.3.4 North America Human Coagulation Factor VIII Production (2021-2032)
1.3.5 Europe Human Coagulation Factor VIII Production (2021-2032)
1.3.6 China Human Coagulation Factor VIII Production (2021-2032)
1.3.7 Korea Human Coagulation Factor VIII Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Human Coagulation Factor VIII Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Human Coagulation Factor VIII Major Market Trends
2 DEMAND SUMMARY
2.1 World Human Coagulation Factor VIII Demand (2021-2032)
2.2 World Human Coagulation Factor VIII Consumption by Region
2.2.1 World Human Coagulation Factor VIII Consumption by Region (2021-2026)
2.2.2 World Human Coagulation Factor VIII Consumption Forecast by Region (2027-2032)
2.3 United States Human Coagulation Factor VIII Consumption (2021-2032)
2.4 China Human Coagulation Factor VIII Consumption (2021-2032)
2.5 Europe Human Coagulation Factor VIII Consumption (2021-2032)
2.6 Japan Human Coagulation Factor VIII Consumption (2021-2032)
2.7 South Korea Human Coagulation Factor VIII Consumption (2021-2032)
2.8 ASEAN Human Coagulation Factor VIII Consumption (2021-2032)
2.9 India Human Coagulation Factor VIII Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Human Coagulation Factor VIII Production Value by Manufacturer (2021-2026)
3.2 World Human Coagulation Factor VIII Production by Manufacturer (2021-2026)
3.3 World Human Coagulation Factor VIII Average Price by Manufacturer (2021-2026)
3.4 Human Coagulation Factor VIII Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Human Coagulation Factor VIII Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Human Coagulation Factor VIII in 2025
3.5.3 Global Concentration Ratios (CR8) for Human Coagulation Factor VIII in 2025
3.6 Human Coagulation Factor VIII Market: Overall Company Footprint Analysis
3.6.1 Human Coagulation Factor VIII Market: Region Footprint
3.6.2 Human Coagulation Factor VIII Market: Company Product Type Footprint
3.6.3 Human Coagulation Factor VIII Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Human Coagulation Factor VIII Production Value Comparison
4.1.1 United States VS China: Human Coagulation Factor VIII Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Human Coagulation Factor VIII Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Human Coagulation Factor VIII Production Comparison
4.2.1 United States VS China: Human Coagulation Factor VIII Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Human Coagulation Factor VIII Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Human Coagulation Factor VIII Consumption Comparison
4.3.1 United States VS China: Human Coagulation Factor VIII Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Human Coagulation Factor VIII Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Human Coagulation Factor VIII Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Human Coagulation Factor VIII Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Human Coagulation Factor VIII Production Value (2021-2026)
4.4.3 United States Based Manufacturers Human Coagulation Factor VIII Production (2021-2026)
4.5 China Based Human Coagulation Factor VIII Manufacturers and Market Share
4.5.1 China Based Human Coagulation Factor VIII Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Human Coagulation Factor VIII Production Value (2021-2026)
4.5.3 China Based Manufacturers Human Coagulation Factor VIII Production (2021-2026)
4.6 Rest of World Based Human Coagulation Factor VIII Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Human Coagulation Factor VIII Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Human Coagulation Factor VIII Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Human Coagulation Factor VIII Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Human Coagulation Factor VIII Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Recombinant Factor VIII
5.2.2 Plasma-derived Factor VIII
5.3 Market Segment by Type
5.3.1 World Human Coagulation Factor VIII Production by Type (2021-2032)
5.3.2 World Human Coagulation Factor VIII Production Value by Type (2021-2032)
5.3.3 World Human Coagulation Factor VIII Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Human Coagulation Factor VIII Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Hemophilia A
6.2.2 Spontanous / Trauma
6.2.3 Surgical
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Human Coagulation Factor VIII Production by Application (2021-2032)
6.3.2 World Human Coagulation Factor VIII Production Value by Application (2021-2032)
6.3.3 World Human Coagulation Factor VIII Average Price by Application (2021-2032)
7 COMPANY PROFILES
7.1 Takeda
7.1.1 Takeda Details
7.1.2 Takeda Major Business
7.1.3 Takeda Human Coagulation Factor VIII Product and Services
7.1.4 Takeda Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.1.5 Takeda Recent Developments/Updates
7.1.6 Takeda Competitive Strengths & Weaknesses
7.2 Bayer
7.2.1 Bayer Details
7.2.2 Bayer Major Business
7.2.3 Bayer Human Coagulation Factor VIII Product and Services
7.2.4 Bayer Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.2.5 Bayer Recent Developments/Updates
7.2.6 Bayer Competitive Strengths & Weaknesses
7.3 CSL
7.3.1 CSL Details
7.3.2 CSL Major Business
7.3.3 CSL Human Coagulation Factor VIII Product and Services
7.3.4 CSL Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.3.5 CSL Recent Developments/Updates
7.3.6 CSL Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer Human Coagulation Factor VIII Product and Services
7.4.4 Pfizer Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 Grifols
7.5.1 Grifols Details
7.5.2 Grifols Major Business
7.5.3 Grifols Human Coagulation Factor VIII Product and Services
7.5.4 Grifols Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.5.5 Grifols Recent Developments/Updates
7.5.6 Grifols Competitive Strengths & Weaknesses
7.6 Biogen
7.6.1 Biogen Details
7.6.2 Biogen Major Business
7.6.3 Biogen Human Coagulation Factor VIII Product and Services
7.6.4 Biogen Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.6.5 Biogen Recent Developments/Updates
7.6.6 Biogen Competitive Strengths & Weaknesses
7.7 Octapharma
7.7.1 Octapharma Details
7.7.2 Octapharma Major Business
7.7.3 Octapharma Human Coagulation Factor VIII Product and Services
7.7.4 Octapharma Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.7.5 Octapharma Recent Developments/Updates
7.7.6 Octapharma Competitive Strengths & Weaknesses
7.8 NovoNordisk
7.8.1 NovoNordisk Details
7.8.2 NovoNordisk Major Business
7.8.3 NovoNordisk Human Coagulation Factor VIII Product and Services
7.8.4 NovoNordisk Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.8.5 NovoNordisk Recent Developments/Updates
7.8.6 NovoNordisk Competitive Strengths & Weaknesses
7.9 Greencross
7.9.1 Greencross Details
7.9.2 Greencross Major Business
7.9.3 Greencross Human Coagulation Factor VIII Product and Services
7.9.4 Greencross Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.9.5 Greencross Recent Developments/Updates
7.9.6 Greencross Competitive Strengths & Weaknesses
7.10 Kedrion
7.10.1 Kedrion Details
7.10.2 Kedrion Major Business
7.10.3 Kedrion Human Coagulation Factor VIII Product and Services
7.10.4 Kedrion Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.10.5 Kedrion Recent Developments/Updates
7.10.6 Kedrion Competitive Strengths & Weaknesses
7.11 BPL
7.11.1 BPL Details
7.11.2 BPL Major Business
7.11.3 BPL Human Coagulation Factor VIII Product and Services
7.11.4 BPL Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.11.5 BPL Recent Developments/Updates
7.11.6 BPL Competitive Strengths & Weaknesses
7.12 Hualan Bio
7.12.1 Hualan Bio Details
7.12.2 Hualan Bio Major Business
7.12.3 Hualan Bio Human Coagulation Factor VIII Product and Services
7.12.4 Hualan Bio Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.12.5 Hualan Bio Recent Developments/Updates
7.12.6 Hualan Bio Competitive Strengths & Weaknesses
7.13 RAAS
7.13.1 RAAS Details
7.13.2 RAAS Major Business
7.13.3 RAAS Human Coagulation Factor VIII Product and Services
7.13.4 RAAS Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.13.5 RAAS Recent Developments/Updates
7.13.6 RAAS Competitive Strengths & Weaknesses
7.14 SinoCellTech
7.14.1 SinoCellTech Details
7.14.2 SinoCellTech Major Business
7.14.3 SinoCellTech Human Coagulation Factor VIII Product and Services
7.14.4 SinoCellTech Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.14.5 SinoCellTech Recent Developments/Updates
7.14.6 SinoCellTech Competitive Strengths & Weaknesses
7.15 Taibang Bio
7.15.1 Taibang Bio Details
7.15.2 Taibang Bio Major Business
7.15.3 Taibang Bio Human Coagulation Factor VIII Product and Services
7.15.4 Taibang Bio Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.15.5 Taibang Bio Recent Developments/Updates
7.15.6 Taibang Bio Competitive Strengths & Weaknesses
7.16 Huarun Boya
7.16.1 Huarun Boya Details
7.16.2 Huarun Boya Major Business
7.16.3 Huarun Boya Human Coagulation Factor VIII Product and Services
7.16.4 Huarun Boya Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.16.5 Huarun Boya Recent Developments/Updates
7.16.6 Huarun Boya Competitive Strengths & Weaknesses
7.17 Shuanglin Bio
7.17.1 Shuanglin Bio Details
7.17.2 Shuanglin Bio Major Business
7.17.3 Shuanglin Bio Human Coagulation Factor VIII Product and Services
7.17.4 Shuanglin Bio Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.17.5 Shuanglin Bio Recent Developments/Updates
7.17.6 Shuanglin Bio Competitive Strengths & Weaknesses
7.18 Yuandashuyang
7.18.1 Yuandashuyang Details
7.18.2 Yuandashuyang Major Business
7.18.3 Yuandashuyang Human Coagulation Factor VIII Product and Services
7.18.4 Yuandashuyang Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.18.5 Yuandashuyang Recent Developments/Updates
7.18.6 Yuandashuyang Competitive Strengths & Weaknesses
7.19 Weiguang Bio
7.19.1 Weiguang Bio Details
7.19.2 Weiguang Bio Major Business
7.19.3 Weiguang Bio Human Coagulation Factor VIII Product and Services
7.19.4 Weiguang Bio Human Coagulation Factor VIII Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.19.5 Weiguang Bio Recent Developments/Updates
7.19.6 Weiguang Bio Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Human Coagulation Factor VIII Industry Chain
8.2 Human Coagulation Factor VIII Upstream Analysis
8.2.1 Human Coagulation Factor VIII Core Raw Materials
8.2.2 Main Manufacturers of Human Coagulation Factor VIII Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Human Coagulation Factor VIII Production Mode
8.6 Human Coagulation Factor VIII Procurement Model
8.7 Human Coagulation Factor VIII Industry Sales Model and Sales Channels
8.7.1 Human Coagulation Factor VIII Sales Model
8.7.2 Human Coagulation Factor VIII Typical Distributors
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Human Coagulation Factor VIII Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Human Coagulation Factor VIII Production Value by Region (2021-2026) & (USD Million)
Table 3. World Human Coagulation Factor VIII Production Value by Region (2027-2032) & (USD Million)
Table 4. World Human Coagulation Factor VIII Production Value Market Share by Region (2021-2026)
Table 5. World Human Coagulation Factor VIII Production Value Market Share by Region (2027-2032)
Table 6. World Human Coagulation Factor VIII Production by Region (2021-2026) & (K Bottles)
Table 7. World Human Coagulation Factor VIII Production by Region (2027-2032) & (K Bottles)
Table 8. World Human Coagulation Factor VIII Production Market Share by Region (2021-2026)
Table 9. World Human Coagulation Factor VIII Production Market Share by Region (2027-2032)
Table 10. World Human Coagulation Factor VIII Average Price by Region (2021-2026) & (USD/Bottle)
Table 11. World Human Coagulation Factor VIII Average Price by Region (2027-2032) & (USD/Bottle)
Table 12. Human Coagulation Factor VIII Major Market Trends
Table 13. World Human Coagulation Factor VIII Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Bottles)
Table 14. World Human Coagulation Factor VIII Consumption by Region (2021-2026) & (K Bottles)
Table 15. World Human Coagulation Factor VIII Consumption Forecast by Region (2027-2032) & (K Bottles)
Table 16. World Human Coagulation Factor VIII Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Human Coagulation Factor VIII Producers in 2025
Table 18. World Human Coagulation Factor VIII Production by Manufacturer (2021-2026) & (K Bottles)
Table 19. Production Market Share of Key Human Coagulation Factor VIII Producers in 2025
Table 20. World Human Coagulation Factor VIII Average Price by Manufacturer (2021-2026) & (USD/Bottle)
Table 21. Global Human Coagulation Factor VIII Company Evaluation Quadrant
Table 22. World Human Coagulation Factor VIII Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Human Coagulation Factor VIII Production Site of Key Manufacturer
Table 24. Human Coagulation Factor VIII Market: Company Product Type Footprint
Table 25. Human Coagulation Factor VIII Market: Company Product Application Footprint
Table 26. Human Coagulation Factor VIII Competitive Factors
Table 27. Human Coagulation Factor VIII New Entrant and Capacity Expansion Plans
Table 28. Human Coagulation Factor VIII Mergers & Acquisitions Activity
Table 29. United States VS China Human Coagulation Factor VIII Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Human Coagulation Factor VIII Production Comparison, (2021 & 2025 & 2032) & (K Bottles)
Table 31. United States VS China Human Coagulation Factor VIII Consumption Comparison, (2021 & 2025 & 2032) & (K Bottles)
Table 32. United States Based Human Coagulation Factor VIII Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Human Coagulation Factor VIII Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Human Coagulation Factor VIII Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Human Coagulation Factor VIII Production (2021-2026) & (K Bottles)
Table 36. United States Based Manufacturers Human Coagulation Factor VIII Production Market Share (2021-2026)
Table 37. China Based Human Coagulation Factor VIII Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Human Coagulation Factor VIII Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Human Coagulation Factor VIII Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Human Coagulation Factor VIII Production, (2021-2026) & (K Bottles)
Table 41. China Based Manufacturers Human Coagulation Factor VIII Production Market Share (2021-2026)
Table 42. Rest of World Based Human Coagulation Factor VIII Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Human Coagulation Factor VIII Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Human Coagulation Factor VIII Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Human Coagulation Factor VIII Production, (2021-2026) & (K Bottles)
Table 46. Rest of World Based Manufacturers Human Coagulation Factor VIII Production Market Share (2021-2026)
Table 47. World Human Coagulation Factor VIII Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Human Coagulation Factor VIII Production by Type (2021-2026) & (K Bottles)
Table 49. World Human Coagulation Factor VIII Production by Type (2027-2032) & (K Bottles)
Table 50. World Human Coagulation Factor VIII Production Value by Type (2021-2026) & (USD Million)
Table 51. World Human Coagulation Factor VIII Production Value by Type (2027-2032) & (USD Million)
Table 52. World Human Coagulation Factor VIII Average Price by Type (2021-2026) & (USD/Bottle)
Table 53. World Human Coagulation Factor VIII Average Price by Type (2027-2032) & (USD/Bottle)
Table 54. World Human Coagulation Factor VIII Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Human Coagulation Factor VIII Production by Application (2021-2026) & (K Bottles)
Table 56. World Human Coagulation Factor VIII Production by Application (2027-2032) & (K Bottles)
Table 57. World Human Coagulation Factor VIII Production Value by Application (2021-2026) & (USD Million)
Table 58. World Human Coagulation Factor VIII Production Value by Application (2027-2032) & (USD Million)
Table 59. World Human Coagulation Factor VIII Average Price by Application (2021-2026) & (USD/Bottle)
Table 60. World Human Coagulation Factor VIII Average Price by Application (2027-2032) & (USD/Bottle)
Table 61. Takeda Basic Information, Manufacturing Base and Competitors
Table 62. Takeda Major Business
Table 63. Takeda Human Coagulation Factor VIII Product and Services
Table 64. Takeda Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Takeda Recent Developments/Updates
Table 66. Takeda Competitive Strengths & Weaknesses
Table 67. Bayer Basic Information, Manufacturing Base and Competitors
Table 68. Bayer Major Business
Table 69. Bayer Human Coagulation Factor VIII Product and Services
Table 70. Bayer Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. Bayer Recent Developments/Updates
Table 72. Bayer Competitive Strengths & Weaknesses
Table 73. CSL Basic Information, Manufacturing Base and Competitors
Table 74. CSL Major Business
Table 75. CSL Human Coagulation Factor VIII Product and Services
Table 76. CSL Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. CSL Recent Developments/Updates
Table 78. CSL Competitive Strengths & Weaknesses
Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Major Business
Table 81. Pfizer Human Coagulation Factor VIII Product and Services
Table 82. Pfizer Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Pfizer Recent Developments/Updates
Table 84. Pfizer Competitive Strengths & Weaknesses
Table 85. Grifols Basic Information, Manufacturing Base and Competitors
Table 86. Grifols Major Business
Table 87. Grifols Human Coagulation Factor VIII Product and Services
Table 88. Grifols Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Grifols Recent Developments/Updates
Table 90. Grifols Competitive Strengths & Weaknesses
Table 91. Biogen Basic Information, Manufacturing Base and Competitors
Table 92. Biogen Major Business
Table 93. Biogen Human Coagulation Factor VIII Product and Services
Table 94. Biogen Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Biogen Recent Developments/Updates
Table 96. Biogen Competitive Strengths & Weaknesses
Table 97. Octapharma Basic Information, Manufacturing Base and Competitors
Table 98. Octapharma Major Business
Table 99. Octapharma Human Coagulation Factor VIII Product and Services
Table 100. Octapharma Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. Octapharma Recent Developments/Updates
Table 102. Octapharma Competitive Strengths & Weaknesses
Table 103. NovoNordisk Basic Information, Manufacturing Base and Competitors
Table 104. NovoNordisk Major Business
Table 105. NovoNordisk Human Coagulation Factor VIII Product and Services
Table 106. NovoNordisk Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. NovoNordisk Recent Developments/Updates
Table 108. NovoNordisk Competitive Strengths & Weaknesses
Table 109. Greencross Basic Information, Manufacturing Base and Competitors
Table 110. Greencross Major Business
Table 111. Greencross Human Coagulation Factor VIII Product and Services
Table 112. Greencross Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. Greencross Recent Developments/Updates
Table 114. Greencross Competitive Strengths & Weaknesses
Table 115. Kedrion Basic Information, Manufacturing Base and Competitors
Table 116. Kedrion Major Business
Table 117. Kedrion Human Coagulation Factor VIII Product and Services
Table 118. Kedrion Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Kedrion Recent Developments/Updates
Table 120. Kedrion Competitive Strengths & Weaknesses
Table 121. BPL Basic Information, Manufacturing Base and Competitors
Table 122. BPL Major Business
Table 123. BPL Human Coagulation Factor VIII Product and Services
Table 124. BPL Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. BPL Recent Developments/Updates
Table 126. BPL Competitive Strengths & Weaknesses
Table 127. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 128. Hualan Bio Major Business
Table 129. Hualan Bio Human Coagulation Factor VIII Product and Services
Table 130. Hualan Bio Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. Hualan Bio Recent Developments/Updates
Table 132. Hualan Bio Competitive Strengths & Weaknesses
Table 133. RAAS Basic Information, Manufacturing Base and Competitors
Table 134. RAAS Major Business
Table 135. RAAS Human Coagulation Factor VIII Product and Services
Table 136. RAAS Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 137. RAAS Recent Developments/Updates
Table 138. RAAS Competitive Strengths & Weaknesses
Table 139. SinoCellTech Basic Information, Manufacturing Base and Competitors
Table 140. SinoCellTech Major Business
Table 141. SinoCellTech Human Coagulation Factor VIII Product and Services
Table 142. SinoCellTech Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 143. SinoCellTech Recent Developments/Updates
Table 144. SinoCellTech Competitive Strengths & Weaknesses
Table 145. Taibang Bio Basic Information, Manufacturing Base and Competitors
Table 146. Taibang Bio Major Business
Table 147. Taibang Bio Human Coagulation Factor VIII Product and Services
Table 148. Taibang Bio Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 149. Taibang Bio Recent Developments/Updates
Table 150. Taibang Bio Competitive Strengths & Weaknesses
Table 151. Huarun Boya Basic Information, Manufacturing Base and Competitors
Table 152. Huarun Boya Major Business
Table 153. Huarun Boya Human Coagulation Factor VIII Product and Services
Table 154. Huarun Boya Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 155. Huarun Boya Recent Developments/Updates
Table 156. Huarun Boya Competitive Strengths & Weaknesses
Table 157. Shuanglin Bio Basic Information, Manufacturing Base and Competitors
Table 158. Shuanglin Bio Major Business
Table 159. Shuanglin Bio Human Coagulation Factor VIII Product and Services
Table 160. Shuanglin Bio Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 161. Shuanglin Bio Recent Developments/Updates
Table 162. Shuanglin Bio Competitive Strengths & Weaknesses
Table 163. Yuandashuyang Basic Information, Manufacturing Base and Competitors
Table 164. Yuandashuyang Major Business
Table 165. Yuandashuyang Human Coagulation Factor VIII Product and Services
Table 166. Yuandashuyang Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 167. Yuandashuyang Recent Developments/Updates
Table 168. Yuandashuyang Competitive Strengths & Weaknesses
Table 169. Weiguang Bio Basic Information, Manufacturing Base and Competitors
Table 170. Weiguang Bio Major Business
Table 171. Weiguang Bio Human Coagulation Factor VIII Product and Services
Table 172. Weiguang Bio Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 173. Weiguang Bio Recent Developments/Updates
Table 174. Weiguang Bio Competitive Strengths & Weaknesses
Table 175. Global Key Players of Human Coagulation Factor VIII Upstream (Raw Materials)
Table 176. Global Human Coagulation Factor VIII Typical Customers
Table 177. Human Coagulation Factor VIII Typical Distributors
Table 1. World Human Coagulation Factor VIII Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Human Coagulation Factor VIII Production Value by Region (2021-2026) & (USD Million)
Table 3. World Human Coagulation Factor VIII Production Value by Region (2027-2032) & (USD Million)
Table 4. World Human Coagulation Factor VIII Production Value Market Share by Region (2021-2026)
Table 5. World Human Coagulation Factor VIII Production Value Market Share by Region (2027-2032)
Table 6. World Human Coagulation Factor VIII Production by Region (2021-2026) & (K Bottles)
Table 7. World Human Coagulation Factor VIII Production by Region (2027-2032) & (K Bottles)
Table 8. World Human Coagulation Factor VIII Production Market Share by Region (2021-2026)
Table 9. World Human Coagulation Factor VIII Production Market Share by Region (2027-2032)
Table 10. World Human Coagulation Factor VIII Average Price by Region (2021-2026) & (USD/Bottle)
Table 11. World Human Coagulation Factor VIII Average Price by Region (2027-2032) & (USD/Bottle)
Table 12. Human Coagulation Factor VIII Major Market Trends
Table 13. World Human Coagulation Factor VIII Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Bottles)
Table 14. World Human Coagulation Factor VIII Consumption by Region (2021-2026) & (K Bottles)
Table 15. World Human Coagulation Factor VIII Consumption Forecast by Region (2027-2032) & (K Bottles)
Table 16. World Human Coagulation Factor VIII Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Human Coagulation Factor VIII Producers in 2025
Table 18. World Human Coagulation Factor VIII Production by Manufacturer (2021-2026) & (K Bottles)
Table 19. Production Market Share of Key Human Coagulation Factor VIII Producers in 2025
Table 20. World Human Coagulation Factor VIII Average Price by Manufacturer (2021-2026) & (USD/Bottle)
Table 21. Global Human Coagulation Factor VIII Company Evaluation Quadrant
Table 22. World Human Coagulation Factor VIII Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Human Coagulation Factor VIII Production Site of Key Manufacturer
Table 24. Human Coagulation Factor VIII Market: Company Product Type Footprint
Table 25. Human Coagulation Factor VIII Market: Company Product Application Footprint
Table 26. Human Coagulation Factor VIII Competitive Factors
Table 27. Human Coagulation Factor VIII New Entrant and Capacity Expansion Plans
Table 28. Human Coagulation Factor VIII Mergers & Acquisitions Activity
Table 29. United States VS China Human Coagulation Factor VIII Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Human Coagulation Factor VIII Production Comparison, (2021 & 2025 & 2032) & (K Bottles)
Table 31. United States VS China Human Coagulation Factor VIII Consumption Comparison, (2021 & 2025 & 2032) & (K Bottles)
Table 32. United States Based Human Coagulation Factor VIII Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Human Coagulation Factor VIII Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Human Coagulation Factor VIII Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Human Coagulation Factor VIII Production (2021-2026) & (K Bottles)
Table 36. United States Based Manufacturers Human Coagulation Factor VIII Production Market Share (2021-2026)
Table 37. China Based Human Coagulation Factor VIII Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Human Coagulation Factor VIII Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Human Coagulation Factor VIII Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Human Coagulation Factor VIII Production, (2021-2026) & (K Bottles)
Table 41. China Based Manufacturers Human Coagulation Factor VIII Production Market Share (2021-2026)
Table 42. Rest of World Based Human Coagulation Factor VIII Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Human Coagulation Factor VIII Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Human Coagulation Factor VIII Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Human Coagulation Factor VIII Production, (2021-2026) & (K Bottles)
Table 46. Rest of World Based Manufacturers Human Coagulation Factor VIII Production Market Share (2021-2026)
Table 47. World Human Coagulation Factor VIII Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Human Coagulation Factor VIII Production by Type (2021-2026) & (K Bottles)
Table 49. World Human Coagulation Factor VIII Production by Type (2027-2032) & (K Bottles)
Table 50. World Human Coagulation Factor VIII Production Value by Type (2021-2026) & (USD Million)
Table 51. World Human Coagulation Factor VIII Production Value by Type (2027-2032) & (USD Million)
Table 52. World Human Coagulation Factor VIII Average Price by Type (2021-2026) & (USD/Bottle)
Table 53. World Human Coagulation Factor VIII Average Price by Type (2027-2032) & (USD/Bottle)
Table 54. World Human Coagulation Factor VIII Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Human Coagulation Factor VIII Production by Application (2021-2026) & (K Bottles)
Table 56. World Human Coagulation Factor VIII Production by Application (2027-2032) & (K Bottles)
Table 57. World Human Coagulation Factor VIII Production Value by Application (2021-2026) & (USD Million)
Table 58. World Human Coagulation Factor VIII Production Value by Application (2027-2032) & (USD Million)
Table 59. World Human Coagulation Factor VIII Average Price by Application (2021-2026) & (USD/Bottle)
Table 60. World Human Coagulation Factor VIII Average Price by Application (2027-2032) & (USD/Bottle)
Table 61. Takeda Basic Information, Manufacturing Base and Competitors
Table 62. Takeda Major Business
Table 63. Takeda Human Coagulation Factor VIII Product and Services
Table 64. Takeda Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Takeda Recent Developments/Updates
Table 66. Takeda Competitive Strengths & Weaknesses
Table 67. Bayer Basic Information, Manufacturing Base and Competitors
Table 68. Bayer Major Business
Table 69. Bayer Human Coagulation Factor VIII Product and Services
Table 70. Bayer Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. Bayer Recent Developments/Updates
Table 72. Bayer Competitive Strengths & Weaknesses
Table 73. CSL Basic Information, Manufacturing Base and Competitors
Table 74. CSL Major Business
Table 75. CSL Human Coagulation Factor VIII Product and Services
Table 76. CSL Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. CSL Recent Developments/Updates
Table 78. CSL Competitive Strengths & Weaknesses
Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Major Business
Table 81. Pfizer Human Coagulation Factor VIII Product and Services
Table 82. Pfizer Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Pfizer Recent Developments/Updates
Table 84. Pfizer Competitive Strengths & Weaknesses
Table 85. Grifols Basic Information, Manufacturing Base and Competitors
Table 86. Grifols Major Business
Table 87. Grifols Human Coagulation Factor VIII Product and Services
Table 88. Grifols Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Grifols Recent Developments/Updates
Table 90. Grifols Competitive Strengths & Weaknesses
Table 91. Biogen Basic Information, Manufacturing Base and Competitors
Table 92. Biogen Major Business
Table 93. Biogen Human Coagulation Factor VIII Product and Services
Table 94. Biogen Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Biogen Recent Developments/Updates
Table 96. Biogen Competitive Strengths & Weaknesses
Table 97. Octapharma Basic Information, Manufacturing Base and Competitors
Table 98. Octapharma Major Business
Table 99. Octapharma Human Coagulation Factor VIII Product and Services
Table 100. Octapharma Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. Octapharma Recent Developments/Updates
Table 102. Octapharma Competitive Strengths & Weaknesses
Table 103. NovoNordisk Basic Information, Manufacturing Base and Competitors
Table 104. NovoNordisk Major Business
Table 105. NovoNordisk Human Coagulation Factor VIII Product and Services
Table 106. NovoNordisk Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. NovoNordisk Recent Developments/Updates
Table 108. NovoNordisk Competitive Strengths & Weaknesses
Table 109. Greencross Basic Information, Manufacturing Base and Competitors
Table 110. Greencross Major Business
Table 111. Greencross Human Coagulation Factor VIII Product and Services
Table 112. Greencross Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. Greencross Recent Developments/Updates
Table 114. Greencross Competitive Strengths & Weaknesses
Table 115. Kedrion Basic Information, Manufacturing Base and Competitors
Table 116. Kedrion Major Business
Table 117. Kedrion Human Coagulation Factor VIII Product and Services
Table 118. Kedrion Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Kedrion Recent Developments/Updates
Table 120. Kedrion Competitive Strengths & Weaknesses
Table 121. BPL Basic Information, Manufacturing Base and Competitors
Table 122. BPL Major Business
Table 123. BPL Human Coagulation Factor VIII Product and Services
Table 124. BPL Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. BPL Recent Developments/Updates
Table 126. BPL Competitive Strengths & Weaknesses
Table 127. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 128. Hualan Bio Major Business
Table 129. Hualan Bio Human Coagulation Factor VIII Product and Services
Table 130. Hualan Bio Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. Hualan Bio Recent Developments/Updates
Table 132. Hualan Bio Competitive Strengths & Weaknesses
Table 133. RAAS Basic Information, Manufacturing Base and Competitors
Table 134. RAAS Major Business
Table 135. RAAS Human Coagulation Factor VIII Product and Services
Table 136. RAAS Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 137. RAAS Recent Developments/Updates
Table 138. RAAS Competitive Strengths & Weaknesses
Table 139. SinoCellTech Basic Information, Manufacturing Base and Competitors
Table 140. SinoCellTech Major Business
Table 141. SinoCellTech Human Coagulation Factor VIII Product and Services
Table 142. SinoCellTech Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 143. SinoCellTech Recent Developments/Updates
Table 144. SinoCellTech Competitive Strengths & Weaknesses
Table 145. Taibang Bio Basic Information, Manufacturing Base and Competitors
Table 146. Taibang Bio Major Business
Table 147. Taibang Bio Human Coagulation Factor VIII Product and Services
Table 148. Taibang Bio Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 149. Taibang Bio Recent Developments/Updates
Table 150. Taibang Bio Competitive Strengths & Weaknesses
Table 151. Huarun Boya Basic Information, Manufacturing Base and Competitors
Table 152. Huarun Boya Major Business
Table 153. Huarun Boya Human Coagulation Factor VIII Product and Services
Table 154. Huarun Boya Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 155. Huarun Boya Recent Developments/Updates
Table 156. Huarun Boya Competitive Strengths & Weaknesses
Table 157. Shuanglin Bio Basic Information, Manufacturing Base and Competitors
Table 158. Shuanglin Bio Major Business
Table 159. Shuanglin Bio Human Coagulation Factor VIII Product and Services
Table 160. Shuanglin Bio Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 161. Shuanglin Bio Recent Developments/Updates
Table 162. Shuanglin Bio Competitive Strengths & Weaknesses
Table 163. Yuandashuyang Basic Information, Manufacturing Base and Competitors
Table 164. Yuandashuyang Major Business
Table 165. Yuandashuyang Human Coagulation Factor VIII Product and Services
Table 166. Yuandashuyang Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 167. Yuandashuyang Recent Developments/Updates
Table 168. Yuandashuyang Competitive Strengths & Weaknesses
Table 169. Weiguang Bio Basic Information, Manufacturing Base and Competitors
Table 170. Weiguang Bio Major Business
Table 171. Weiguang Bio Human Coagulation Factor VIII Product and Services
Table 172. Weiguang Bio Human Coagulation Factor VIII Production (K Bottles), Price (USD/Bottle), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 173. Weiguang Bio Recent Developments/Updates
Table 174. Weiguang Bio Competitive Strengths & Weaknesses
Table 175. Global Key Players of Human Coagulation Factor VIII Upstream (Raw Materials)
Table 176. Global Human Coagulation Factor VIII Typical Customers
Table 177. Human Coagulation Factor VIII Typical Distributors
LIST OF FIGURES
Figure 1. Human Coagulation Factor VIII Picture
Figure 2. World Human Coagulation Factor VIII Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Human Coagulation Factor VIII Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Human Coagulation Factor VIII Production (2021-2032) & (K Bottles)
Figure 5. World Human Coagulation Factor VIII Average Price (2021-2032) & (USD/Bottle)
Figure 6. World Human Coagulation Factor VIII Production Value Market Share by Region (2021-2032)
Figure 7. World Human Coagulation Factor VIII Production Market Share by Region (2021-2032)
Figure 8. North America Human Coagulation Factor VIII Production (2021-2032) & (K Bottles)
Figure 9. Europe Human Coagulation Factor VIII Production (2021-2032) & (K Bottles)
Figure 10. China Human Coagulation Factor VIII Production (2021-2032) & (K Bottles)
Figure 11. Korea Human Coagulation Factor VIII Production (2021-2032) & (K Bottles)
Figure 12. Human Coagulation Factor VIII Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Human Coagulation Factor VIII Consumption (2021-2032) & (K Bottles)
Figure 15. World Human Coagulation Factor VIII Consumption Market Share by Region (2021-2032)
Figure 16. United States Human Coagulation Factor VIII Consumption (2021-2032) & (K Bottles)
Figure 17. China Human Coagulation Factor VIII Consumption (2021-2032) & (K Bottles)
Figure 18. Europe Human Coagulation Factor VIII Consumption (2021-2032) & (K Bottles)
Figure 19. Japan Human Coagulation Factor VIII Consumption (2021-2032) & (K Bottles)
Figure 20. South Korea Human Coagulation Factor VIII Consumption (2021-2032) & (K Bottles)
Figure 21. ASEAN Human Coagulation Factor VIII Consumption (2021-2032) & (K Bottles)
Figure 22. India Human Coagulation Factor VIII Consumption (2021-2032) & (K Bottles)
Figure 23. Producer Shipments of Human Coagulation Factor VIII by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Human Coagulation Factor VIII Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Human Coagulation Factor VIII Markets in 2025
Figure 26. United States VS China: Human Coagulation Factor VIII Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Human Coagulation Factor VIII Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Human Coagulation Factor VIII Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Human Coagulation Factor VIII Production Market Share 2025
Figure 30. China Based Manufacturers Human Coagulation Factor VIII Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Human Coagulation Factor VIII Production Market Share 2025
Figure 32. World Human Coagulation Factor VIII Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Human Coagulation Factor VIII Production Value Market Share by Type in 2025
Figure 34. Recombinant Factor VIII
Figure 35. Plasma-derived Factor VIII
Figure 36. World Human Coagulation Factor VIII Production Market Share by Type (2021-2032)
Figure 37. World Human Coagulation Factor VIII Production Value Market Share by Type (2021-2032)
Figure 38. World Human Coagulation Factor VIII Average Price by Type (2021-2032) & (USD/Bottle)
Figure 39. World Human Coagulation Factor VIII Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 40. World Human Coagulation Factor VIII Production Value Market Share by Application in 2025
Figure 41. Hemophilia A
Figure 42. Spontanous / Trauma
Figure 43. Surgical
Figure 44. Other
Figure 45. World Human Coagulation Factor VIII Production Market Share by Application (2021-2032)
Figure 46. World Human Coagulation Factor VIII Production Value Market Share by Application (2021-2032)
Figure 47. World Human Coagulation Factor VIII Average Price by Application (2021-2032) & (USD/Bottle)
Figure 48. Human Coagulation Factor VIII Industry Chain
Figure 49. Human Coagulation Factor VIII Procurement Model
Figure 50. Human Coagulation Factor VIII Sales Model
Figure 51. Human Coagulation Factor VIII Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Human Coagulation Factor VIII Picture
Figure 2. World Human Coagulation Factor VIII Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Human Coagulation Factor VIII Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Human Coagulation Factor VIII Production (2021-2032) & (K Bottles)
Figure 5. World Human Coagulation Factor VIII Average Price (2021-2032) & (USD/Bottle)
Figure 6. World Human Coagulation Factor VIII Production Value Market Share by Region (2021-2032)
Figure 7. World Human Coagulation Factor VIII Production Market Share by Region (2021-2032)
Figure 8. North America Human Coagulation Factor VIII Production (2021-2032) & (K Bottles)
Figure 9. Europe Human Coagulation Factor VIII Production (2021-2032) & (K Bottles)
Figure 10. China Human Coagulation Factor VIII Production (2021-2032) & (K Bottles)
Figure 11. Korea Human Coagulation Factor VIII Production (2021-2032) & (K Bottles)
Figure 12. Human Coagulation Factor VIII Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Human Coagulation Factor VIII Consumption (2021-2032) & (K Bottles)
Figure 15. World Human Coagulation Factor VIII Consumption Market Share by Region (2021-2032)
Figure 16. United States Human Coagulation Factor VIII Consumption (2021-2032) & (K Bottles)
Figure 17. China Human Coagulation Factor VIII Consumption (2021-2032) & (K Bottles)
Figure 18. Europe Human Coagulation Factor VIII Consumption (2021-2032) & (K Bottles)
Figure 19. Japan Human Coagulation Factor VIII Consumption (2021-2032) & (K Bottles)
Figure 20. South Korea Human Coagulation Factor VIII Consumption (2021-2032) & (K Bottles)
Figure 21. ASEAN Human Coagulation Factor VIII Consumption (2021-2032) & (K Bottles)
Figure 22. India Human Coagulation Factor VIII Consumption (2021-2032) & (K Bottles)
Figure 23. Producer Shipments of Human Coagulation Factor VIII by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Human Coagulation Factor VIII Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Human Coagulation Factor VIII Markets in 2025
Figure 26. United States VS China: Human Coagulation Factor VIII Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Human Coagulation Factor VIII Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Human Coagulation Factor VIII Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Human Coagulation Factor VIII Production Market Share 2025
Figure 30. China Based Manufacturers Human Coagulation Factor VIII Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Human Coagulation Factor VIII Production Market Share 2025
Figure 32. World Human Coagulation Factor VIII Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Human Coagulation Factor VIII Production Value Market Share by Type in 2025
Figure 34. Recombinant Factor VIII
Figure 35. Plasma-derived Factor VIII
Figure 36. World Human Coagulation Factor VIII Production Market Share by Type (2021-2032)
Figure 37. World Human Coagulation Factor VIII Production Value Market Share by Type (2021-2032)
Figure 38. World Human Coagulation Factor VIII Average Price by Type (2021-2032) & (USD/Bottle)
Figure 39. World Human Coagulation Factor VIII Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 40. World Human Coagulation Factor VIII Production Value Market Share by Application in 2025
Figure 41. Hemophilia A
Figure 42. Spontanous / Trauma
Figure 43. Surgical
Figure 44. Other
Figure 45. World Human Coagulation Factor VIII Production Market Share by Application (2021-2032)
Figure 46. World Human Coagulation Factor VIII Production Value Market Share by Application (2021-2032)
Figure 47. World Human Coagulation Factor VIII Average Price by Application (2021-2032) & (USD/Bottle)
Figure 48. Human Coagulation Factor VIII Industry Chain
Figure 49. Human Coagulation Factor VIII Procurement Model
Figure 50. Human Coagulation Factor VIII Sales Model
Figure 51. Human Coagulation Factor VIII Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
